nodes	percent_of_prediction	percent_of_DWPC	metapath
Boceprevir—CTSK—gall bladder—bile duct cancer	0.0736	0.143	CbGeAlD
Boceprevir—CTSS—gall bladder—bile duct cancer	0.0645	0.125	CbGeAlD
Boceprevir—CTSV—pancreas—bile duct cancer	0.0551	0.107	CbGeAlD
Boceprevir—CTSL—pancreas—bile duct cancer	0.045	0.0874	CbGeAlD
Boceprevir—CTSK—pancreas—bile duct cancer	0.0339	0.0658	CbGeAlD
Boceprevir—CMA1—liver—bile duct cancer	0.0335	0.065	CbGeAlD
Boceprevir—CTSS—pancreas—bile duct cancer	0.0297	0.0577	CbGeAlD
Boceprevir—CTSL—liver—bile duct cancer	0.0286	0.0556	CbGeAlD
Boceprevir—CMA1—lymph node—bile duct cancer	0.0257	0.0498	CbGeAlD
Boceprevir—CTSL—lymph node—bile duct cancer	0.022	0.0426	CbGeAlD
Boceprevir—CTSK—liver—bile duct cancer	0.0216	0.0419	CbGeAlD
Boceprevir—CTSS—liver—bile duct cancer	0.0189	0.0367	CbGeAlD
Boceprevir—CTSV—Activation of Matrix Metalloproteinases—MMP2—bile duct cancer	0.0182	0.0374	CbGpPWpGaD
Boceprevir—CMA1—ACE Inhibitor Pathway—TGFB1—bile duct cancer	0.0173	0.0358	CbGpPWpGaD
Boceprevir—CMA1—Activation of Matrix Metalloproteinases—MMP2—bile duct cancer	0.0169	0.0348	CbGpPWpGaD
Boceprevir—CTSK—lymph node—bile duct cancer	0.0165	0.0321	CbGeAlD
Boceprevir—CTSL—Collagen degradation—MMP2—bile duct cancer	0.0158	0.0326	CbGpPWpGaD
Boceprevir—CTSK—Activation of Matrix Metalloproteinases—MMP2—bile duct cancer	0.015	0.031	CbGpPWpGaD
Boceprevir—CTSS—lymph node—bile duct cancer	0.0145	0.0281	CbGeAlD
Boceprevir—CTSV—Activation of Matrix Metalloproteinases—MMP9—bile duct cancer	0.0136	0.0281	CbGpPWpGaD
Boceprevir—CTSK—Collagen degradation—MMP2—bile duct cancer	0.0131	0.027	CbGpPWpGaD
Boceprevir—CMA1—Activation of Matrix Metalloproteinases—MMP9—bile duct cancer	0.0127	0.0262	CbGpPWpGaD
Boceprevir—CTSL—Collagen degradation—MMP9—bile duct cancer	0.0119	0.0245	CbGpPWpGaD
Boceprevir—CTSK—Activation of Matrix Metalloproteinases—MMP9—bile duct cancer	0.0113	0.0233	CbGpPWpGaD
Boceprevir—CYP3A5—pancreas—bile duct cancer	0.00987	0.0192	CbGeAlD
Boceprevir—CTSK—Collagen degradation—MMP9—bile duct cancer	0.00986	0.0203	CbGpPWpGaD
Boceprevir—CTSL—Assembly of collagen fibrils and other multimeric structures—MMP9—bile duct cancer	0.00925	0.0191	CbGpPWpGaD
Boceprevir—CTSV—Assembly of collagen fibrils and other multimeric structures—MMP9—bile duct cancer	0.00925	0.0191	CbGpPWpGaD
Boceprevir—CTSV—Extracellular matrix organization—TNC—bile duct cancer	0.00811	0.0167	CbGpPWpGaD
Boceprevir—CTSL—Extracellular matrix organization—TNC—bile duct cancer	0.00811	0.0167	CbGpPWpGaD
Boceprevir—CTSL—Degradation of the extracellular matrix—MMP2—bile duct cancer	0.00801	0.0165	CbGpPWpGaD
Boceprevir—CTSV—Degradation of the extracellular matrix—MMP2—bile duct cancer	0.00801	0.0165	CbGpPWpGaD
Boceprevir—CTSV—Endochondral Ossification—MMP9—bile duct cancer	0.00784	0.0162	CbGpPWpGaD
Boceprevir—CMA1—Extracellular matrix organization—TNC—bile duct cancer	0.00754	0.0155	CbGpPWpGaD
Boceprevir—CMA1—Degradation of the extracellular matrix—MMP2—bile duct cancer	0.00745	0.0154	CbGpPWpGaD
Boceprevir—CTSK—Extracellular matrix organization—TNC—bile duct cancer	0.00672	0.0138	CbGpPWpGaD
Boceprevir—CTSK—Degradation of the extracellular matrix—MMP2—bile duct cancer	0.00664	0.0137	CbGpPWpGaD
Boceprevir—CTSV—Endochondral Ossification—TGFB1—bile duct cancer	0.00646	0.0133	CbGpPWpGaD
Boceprevir—CMA1—Metabolism of proteins—MUC1—bile duct cancer	0.00637	0.0131	CbGpPWpGaD
Boceprevir—CMA1—Metabolism of proteins—MUC4—bile duct cancer	0.00637	0.0131	CbGpPWpGaD
Boceprevir—CTSS—Assembly of collagen fibrils and other multimeric structures—MMP9—bile duct cancer	0.00632	0.013	CbGpPWpGaD
Boceprevir—CTSL—Collagen formation—MMP9—bile duct cancer	0.00631	0.013	CbGpPWpGaD
Boceprevir—CTSV—Collagen formation—MMP9—bile duct cancer	0.00631	0.013	CbGpPWpGaD
Boceprevir—CYP3A5—liver—bile duct cancer	0.00628	0.0122	CbGeAlD
Boceprevir—CTSV—Degradation of the extracellular matrix—MMP9—bile duct cancer	0.00602	0.0124	CbGpPWpGaD
Boceprevir—CTSL—Degradation of the extracellular matrix—MMP9—bile duct cancer	0.00602	0.0124	CbGpPWpGaD
Boceprevir—CTSL—Primary Focal Segmental Glomerulosclerosis FSGS—TGFB1—bile duct cancer	0.00588	0.0121	CbGpPWpGaD
Boceprevir—CMA1—Degradation of the extracellular matrix—MMP9—bile duct cancer	0.0056	0.0115	CbGpPWpGaD
Boceprevir—CTSS—Extracellular matrix organization—TNC—bile duct cancer	0.00553	0.0114	CbGpPWpGaD
Boceprevir—CTSS—Degradation of the extracellular matrix—MMP2—bile duct cancer	0.00547	0.0113	CbGpPWpGaD
Boceprevir—ABCB1—pancreas—bile duct cancer	0.00524	0.0102	CbGeAlD
Boceprevir—CTSK—Degradation of the extracellular matrix—MMP9—bile duct cancer	0.00499	0.0103	CbGpPWpGaD
Boceprevir—CMA1—Metabolism of proteins—MUC2—bile duct cancer	0.00483	0.00996	CbGpPWpGaD
Boceprevir—CYP3A4—liver—bile duct cancer	0.00471	0.00915	CbGeAlD
Boceprevir—CMA1—Signaling by SCF-KIT—ERBB2—bile duct cancer	0.00452	0.00931	CbGpPWpGaD
Boceprevir—CTSS—Collagen formation—MMP9—bile duct cancer	0.0043	0.00887	CbGpPWpGaD
Boceprevir—CTSS—Degradation of the extracellular matrix—MMP9—bile duct cancer	0.00411	0.00847	CbGpPWpGaD
Boceprevir—CMA1—Signaling by SCF-KIT—MMP9—bile duct cancer	0.00387	0.00799	CbGpPWpGaD
Boceprevir—CMA1—Signaling by SCF-KIT—NRAS—bile duct cancer	0.00344	0.00709	CbGpPWpGaD
Boceprevir—CTSV—Extracellular matrix organization—MMP2—bile duct cancer	0.00336	0.00692	CbGpPWpGaD
Boceprevir—CTSL—Extracellular matrix organization—MMP2—bile duct cancer	0.00336	0.00692	CbGpPWpGaD
Boceprevir—ABCB1—liver—bile duct cancer	0.00334	0.00648	CbGeAlD
Boceprevir—CMA1—Signaling by SCF-KIT—EGFR—bile duct cancer	0.00313	0.00646	CbGpPWpGaD
Boceprevir—CMA1—Extracellular matrix organization—MMP2—bile duct cancer	0.00312	0.00644	CbGpPWpGaD
Boceprevir—CMA1—Signaling by SCF-KIT—KRAS—bile duct cancer	0.00296	0.0061	CbGpPWpGaD
Boceprevir—CTSK—Extracellular matrix organization—MMP2—bile duct cancer	0.00278	0.00574	CbGpPWpGaD
Boceprevir—CTSL—Toll-Like Receptors Cascades—IL6—bile duct cancer	0.00259	0.00534	CbGpPWpGaD
Boceprevir—CTSV—Toll-Like Receptors Cascades—IL6—bile duct cancer	0.00259	0.00534	CbGpPWpGaD
Boceprevir—ABCB1—lymph node—bile duct cancer	0.00256	0.00497	CbGeAlD
Boceprevir—CTSV—Extracellular matrix organization—MMP9—bile duct cancer	0.00252	0.0052	CbGpPWpGaD
Boceprevir—CTSL—Extracellular matrix organization—MMP9—bile duct cancer	0.00252	0.0052	CbGpPWpGaD
Boceprevir—CMA1—Signaling by SCF-KIT—HRAS—bile duct cancer	0.00251	0.00518	CbGpPWpGaD
Boceprevir—CMA1—Signaling by SCF-KIT—IL6—bile duct cancer	0.00241	0.00496	CbGpPWpGaD
Boceprevir—CMA1—Extracellular matrix organization—MMP9—bile duct cancer	0.00235	0.00484	CbGpPWpGaD
Boceprevir—CTSS—Extracellular matrix organization—MMP2—bile duct cancer	0.00229	0.00472	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—RNF43—bile duct cancer	0.00228	0.00469	CbGpPWpGaD
Boceprevir—CTSK—Toll-Like Receptors Cascades—IL6—bile duct cancer	0.00214	0.00442	CbGpPWpGaD
Boceprevir—CTSK—Extracellular matrix organization—MMP9—bile duct cancer	0.00209	0.00431	CbGpPWpGaD
Boceprevir—CTSV—Extracellular matrix organization—TGFB1—bile duct cancer	0.00208	0.00429	CbGpPWpGaD
Boceprevir—CTSL—Extracellular matrix organization—TGFB1—bile duct cancer	0.00208	0.00429	CbGpPWpGaD
Boceprevir—CMA1—Extracellular matrix organization—TGFB1—bile duct cancer	0.00193	0.00399	CbGpPWpGaD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—SMAD4—bile duct cancer	0.00179	0.00369	CbGpPWpGaD
Boceprevir—CTSS—Toll-Like Receptors Cascades—IL6—bile duct cancer	0.00177	0.00364	CbGpPWpGaD
Boceprevir—CTSK—Extracellular matrix organization—TGFB1—bile duct cancer	0.00172	0.00355	CbGpPWpGaD
Boceprevir—CTSS—Extracellular matrix organization—MMP9—bile duct cancer	0.00172	0.00355	CbGpPWpGaD
Boceprevir—CTSL—Immune System—HGF—bile duct cancer	0.00159	0.00328	CbGpPWpGaD
Boceprevir—CTSV—Immune System—HGF—bile duct cancer	0.00159	0.00328	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—ERBB2—bile duct cancer	0.00157	0.00324	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—ERBB2—bile duct cancer	0.00157	0.00324	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—ERBB2—bile duct cancer	0.00151	0.00312	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—ERBB2—bile duct cancer	0.00151	0.00312	CbGpPWpGaD
Boceprevir—CMA1—Metabolism of proteins—MMP2—bile duct cancer	0.00146	0.00301	CbGpPWpGaD
Boceprevir—CTSS—Extracellular matrix organization—TGFB1—bile duct cancer	0.00142	0.00293	CbGpPWpGaD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—NOS2—bile duct cancer	0.00133	0.00275	CbGpPWpGaD
Boceprevir—CTSK—Immune System—HGF—bile duct cancer	0.00132	0.00272	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—ERBB2—bile duct cancer	0.0013	0.00269	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—ERBB2—bile duct cancer	0.00125	0.00258	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—NRAS—bile duct cancer	0.0012	0.00247	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—NRAS—bile duct cancer	0.0012	0.00247	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—NRAS—bile duct cancer	0.00115	0.00237	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—NRAS—bile duct cancer	0.00115	0.00237	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—EGFR—bile duct cancer	0.00109	0.00225	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—EGFR—bile duct cancer	0.00109	0.00225	CbGpPWpGaD
Boceprevir—CTSS—Immune System—HGF—bile duct cancer	0.00108	0.00224	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—ERBB2—bile duct cancer	0.00107	0.00221	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—EGFR—bile duct cancer	0.00105	0.00216	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—EGFR—bile duct cancer	0.00105	0.00216	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—TGFBR2—bile duct cancer	0.00104	0.00214	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—ERBB2—bile duct cancer	0.00103	0.00213	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—KRAS—bile duct cancer	0.00103	0.00212	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—KRAS—bile duct cancer	0.00103	0.00212	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—GNAS—bile duct cancer	0.001	0.00207	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—NRAS—bile duct cancer	0.000992	0.00205	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—KRAS—bile duct cancer	0.000989	0.00204	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—KRAS—bile duct cancer	0.000989	0.00204	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—SMAD4—bile duct cancer	0.000984	0.00203	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—NRAS—bile duct cancer	0.000953	0.00196	CbGpPWpGaD
Boceprevir—CTSV—Immune System—ERBB2—bile duct cancer	0.000916	0.00189	CbGpPWpGaD
Boceprevir—CTSL—Immune System—ERBB2—bile duct cancer	0.000916	0.00189	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—EGFR—bile duct cancer	0.000904	0.00186	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—FAR2—bile duct cancer	0.000893	0.00184	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—HRAS—bile duct cancer	0.000876	0.00181	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—HRAS—bile duct cancer	0.000876	0.00181	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—EGFR—bile duct cancer	0.000868	0.00179	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—KRAS—bile duct cancer	0.000854	0.00176	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—HRAS—bile duct cancer	0.000841	0.00173	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—HRAS—bile duct cancer	0.000841	0.00173	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—IL6—bile duct cancer	0.000838	0.00173	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—IL6—bile duct cancer	0.000838	0.00173	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—KRAS—bile duct cancer	0.00082	0.00169	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—NRAS—bile duct cancer	0.000817	0.00168	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—NRAS—bile duct cancer	0.000784	0.00162	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—bile duct cancer	0.000766	0.00158	CbGpPWpGaD
Boceprevir—CTSK—Immune System—ERBB2—bile duct cancer	0.000759	0.00157	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—EGFR—bile duct cancer	0.000744	0.00153	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—HRAS—bile duct cancer	0.000726	0.0015	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—EGFR—bile duct cancer	0.000715	0.00147	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—KRAS—bile duct cancer	0.000703	0.00145	CbGpPWpGaD
Boceprevir—CTSV—Immune System—NRAS—bile duct cancer	0.000697	0.00144	CbGpPWpGaD
Boceprevir—CTSL—Immune System—NRAS—bile duct cancer	0.000697	0.00144	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—HRAS—bile duct cancer	0.000697	0.00144	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—IL6—bile duct cancer	0.000695	0.00143	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—KRAS—bile duct cancer	0.000675	0.00139	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—FAR2—bile duct cancer	0.000674	0.00139	CbGpPWpGaD
Boceprevir—CTSV—Immune System—EGFR—bile duct cancer	0.000635	0.00131	CbGpPWpGaD
Boceprevir—CTSL—Immune System—EGFR—bile duct cancer	0.000635	0.00131	CbGpPWpGaD
Boceprevir—CTSS—Immune System—ERBB2—bile duct cancer	0.000625	0.00129	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—TGFB1—bile duct cancer	0.000614	0.00127	CbGpPWpGaD
Boceprevir—CTSV—Immune System—KRAS—bile duct cancer	0.0006	0.00124	CbGpPWpGaD
Boceprevir—CTSL—Immune System—KRAS—bile duct cancer	0.0006	0.00124	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—HRAS—bile duct cancer	0.000598	0.00123	CbGpPWpGaD
Boceprevir—CTSK—Immune System—NRAS—bile duct cancer	0.000578	0.00119	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—HRAS—bile duct cancer	0.000574	0.00118	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—IL6—bile duct cancer	0.000572	0.00118	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—ERBB2—bile duct cancer	0.000551	0.00114	CbGpPWpGaD
Boceprevir—CTSK—Immune System—EGFR—bile duct cancer	0.000526	0.00109	CbGpPWpGaD
Boceprevir—CTSV—Immune System—HRAS—bile duct cancer	0.00051	0.00105	CbGpPWpGaD
Boceprevir—CTSL—Immune System—HRAS—bile duct cancer	0.00051	0.00105	CbGpPWpGaD
Boceprevir—CTSK—Immune System—KRAS—bile duct cancer	0.000497	0.00103	CbGpPWpGaD
Boceprevir—CTSV—Immune System—IL6—bile duct cancer	0.000488	0.00101	CbGpPWpGaD
Boceprevir—CTSL—Immune System—IL6—bile duct cancer	0.000488	0.00101	CbGpPWpGaD
Boceprevir—CTSS—Immune System—NRAS—bile duct cancer	0.000476	0.000981	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—MMP9—bile duct cancer	0.000473	0.000974	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—IDH2—bile duct cancer	0.000436	0.0009	CbGpPWpGaD
Boceprevir—CTSS—Immune System—EGFR—bile duct cancer	0.000433	0.000894	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—bile duct cancer	0.000429	0.000884	CbGpPWpGaD
Boceprevir—CTSK—Immune System—HRAS—bile duct cancer	0.000423	0.000872	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—NRAS—bile duct cancer	0.000419	0.000864	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bile duct cancer	0.000419	0.000864	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—FAR2—bile duct cancer	0.000415	0.000856	CbGpPWpGaD
Boceprevir—CTSS—Immune System—KRAS—bile duct cancer	0.000409	0.000844	CbGpPWpGaD
Boceprevir—CTSK—Immune System—IL6—bile duct cancer	0.000405	0.000834	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.000399	0.000822	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—TGFB1—bile duct cancer	0.000389	0.000803	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—EGFR—bile duct cancer	0.000382	0.000787	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—IDH1—bile duct cancer	0.000375	0.000774	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—KRAS—bile duct cancer	0.000361	0.000744	CbGpPWpGaD
Boceprevir—CTSS—Immune System—HRAS—bile duct cancer	0.000348	0.000718	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IL6—bile duct cancer	0.000333	0.000687	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—IDH2—bile duct cancer	0.000329	0.000679	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—TP53—bile duct cancer	0.000321	0.000661	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.00031	0.000639	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—HRAS—bile duct cancer	0.000307	0.000632	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—bile duct cancer	0.000303	0.000625	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bile duct cancer	0.000297	0.000613	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—IL6—bile duct cancer	0.000293	0.000605	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—IDH1—bile duct cancer	0.000283	0.000584	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—bile duct cancer	0.000281	0.000579	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bile duct cancer	0.000249	0.000514	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—SLC5A5—bile duct cancer	0.000247	0.00051	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—IDH2—bile duct cancer	0.000203	0.000418	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GNAS—bile duct cancer	0.000192	0.000397	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—SLC5A5—bile duct cancer	0.000187	0.000385	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—IDH1—bile duct cancer	0.000174	0.00036	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GNAS—bile duct cancer	0.000145	0.000299	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—SLC5A5—bile duct cancer	0.000115	0.000237	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PTGS2—bile duct cancer	0.000103	0.000213	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GNAS—bile duct cancer	8.94e-05	0.000184	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PTGS2—bile duct cancer	7.79e-05	0.000161	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PTGS2—bile duct cancer	4.8e-05	9.9e-05	CbGpPWpGaD
